Democrats’ Attempt to Lower Private Drug Prices is Likely to Fail
The Democrats’ most significant attempt to rein in health care costs in the private market— specifically prescription drug costs — is
Read moreLatest News
Can the US Cut Drug Prices Without Sacrificing new Cures?
Congress’s ambitious plans to expand health coverage are crashing up against one of the great questions in health policy: Can they force
Read moreMD Anderson Hit with Ethics Complaint Over Failure to Disclose Clinical Trial results
An advocacy group has filed an ethics complaint with the University of Texas MD Anderson Cancer Center for failing to
Read moreNew Report Finds Biosimilars Could Save States Billions of Dollars Annually
The Biosimilars Forum, in partnership with the Pacific Research Institute (PRI), released a report and interactive tool highlighting the billions of dollars that
Read moreUnderstanding the Seasonality of Part D Expenditures Under the OCM
The Oncology Care Model (OCM) is a voluntary, episode-based oncology-focused payment model from the Centers for Medicare & Medicaid Services
Read moreASCO, COA Release New Oncology Medical Home Standards
With the Center for Medicare & Medicaid Innovation’s (CMMI’s) Oncology Care Model (OCM) poised to sunset in June 2022 (extended
Read more” There Was a Reason my Doctor Prescribed this Specific Medication
Today, patients and healthcare providers from across the Commonwealth met virtually with members of the legislature and their staff to
Read moreOur Health Care System Depends on Physicians Donating their Time
During my third year of residency, I staggered my work hours in an attempt to avoid Boston’s soul-crushing pre-pandemic traffic.
Read moreHospital Merger Imperils Options for End-of-Life Care
In August, the Times Union published an alarming story reporting that end-of-life care will not change as a result of a merger
Read moreDrug Price Transparency Could Return as Top Legislative Issue
Drug prices and who controls them could be back before the General Assembly this winter, as consumer advocates and pharmacy benefit managers
Read more